Hydration is one of the simplest and most effective ways to reduce side effects
Table 1: Initial use restrictions for Wegovy by commercial plans Source: Clarivate Fingertip Restrictions and payers respective prior authorization documents In addition to a relatively light hand in restricting access, Aetna, Cigna, and Anthem list Wegovy on Tier 2 of their commercial and employer formularies, reflecting widespread coverage for the drug (Fingertip Analytics, accessed February 2024)
Eli Lilly, the patent holder for tirzepatide , has launched an aggressive legal campaign against vendors and compounders
Inclusion on a compounding list is an entirely different regulatory pathway
A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)
It is backed by ISO 17025-accredited third-party testing and a none inactive ingredient profile, while product-specific testing is not currently verified by SuppCo